Kitty W.M. Bloemenkamp

Author

Also Known As

Arianne C Lim, Beck-Peccoz, Bloemenkamp, K., Bloemenkamp, K.W.M., Bloemenkamp, Kitty, Dacia D C A Henriquez, Denise van den Berg-Zuiddam, Johan Garssen, Jos J. M. van Roosmalen, K Bloemenkamp

398

Publications

12.9K

Citations

H-Index

134

Concepts

All Affiliations

Leiden University Medical Center University Medical Center Utrecht Radboud University Nijmegen Amsterdam UMC Location University of Amsterdam Máxima Medisch Centrum

About

Kitty W.M. Bloemenkamp is an author at Leiden University Medical Center specializing in medicine, maternal health, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	48	3.7K
2	Public Health	27	44	3.3K
3	Cell Biology	2	2	55
4	Child Development	2	2	116
5	Behavioral Sciences	1	1	10

Kitty W.M. Bloemenkamp

158

Publications

Citations

H-Index

Page 1

	Year	Citations
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial Corine M. Koopmans, Denise Bijlenga, Henk Groen, The Lancet Family MedicineHypertensionGestational HypertensionGynecologyMaternal Health	2009	774
Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT) Kim Boers, Sylvia Vijgen, Denise Bijlenga, BMJ	2010	523
A Randomized Trial of Progesterone in Women with Recurrent Miscarriages Arri Coomarasamy, Helen Williams, Ewa Truchanowicz, New England Journal of Medicine	2015	298
Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial Sophie Liem, Ewoud Schuit, Maud A Hegeman, The Lancet Family MedicineCervical HealthPreterm LaborReproductive HealthGynecology	2013	293
Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial Marta Jozwiak, Katrien Oude Rengerink, Marjan Benthem, The Lancet FertilityProbaat TrialReproductive HealthGynecologyMaternal Health	2011	220
Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial David P. van der Ham, Sylvia Vijgen, Jan G. Nijhuis, PLoS Medicine	2012	203
Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial David P. van der Ham, Jantien L. van der Heyden, Brent C. Opmeer, American Journal of Obstetrics and Gynecology Ppromexil-2 TrialPreterm Premature Rupture Of MembranesSurgeryMedicine	2012	194
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial Kim Broekhuijsen, Gert-Jan van Baaren, Maria G. van Pampus, The Lancet HypertensionGestational HypertensionPregnancy DisordersHypertensive DisordersPediatrics	2015	191
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia Jantien Visser, Veli‐Matti Ulander, Frans M. Helmerhorst, Thrombosis and Haemostasis Reproductive HealthGynecologyPharmacotherapyHigh-risk PregnancyThrombosis	2010	173
Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study Mercedes Bonet, Vanessa Brizuela, Edgardo Ábalos, The Lancet Global Health	2020	169

Page 1